Clinical Trial Update: A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

View source ↗

Summary

A completed clinical trial evaluating Paxlovid (nirmatrelvir/ritonavir) for COVID-19 in Saudi Arabia has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• PAXLOVID (Nirmatrelvir and ritonavir)

Snippet

Sponsor: Pfizer | Conditions: Covid-19 | Status: COMPLETED | Results posted: 2025-04-29